This post was originally published on this site
J&J announced earnings per share of $2.13 on revenue of $24.8B. Analysts polled by Investing.com anticipated EPS of $2.12 on revenue of $25.28B.
J&J shares are down 4% from the beginning of the year, still down 9.42% from its 52 week high of $179.92 set on August 20, 2021. They are outperforming the S&P 500 which is down 7.47% from the start of the year.
J&J’s report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
Intuitive Surgical had beat expectations on Thursday with fourth quarter EPS of $1.3 on revenue of $1.55B, compared to forecast for EPS of $1.28 on revenue of $1.52B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
